Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study

[1]  T. S. Wilkinson,et al.  The human cationic host defense peptide LL‐37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system , 2006, Journal of leukocyte biology.

[2]  K. Mandal,et al.  Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Lumsden,et al.  Chlamydia pneumoniae and vascular disease: an update. , 2006, Journal of vascular surgery.

[4]  R. Hancock,et al.  Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. , 2006, American journal of respiratory cell and molecular biology.

[5]  I. Nagaoka,et al.  An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X71 , 2006, The Journal of Immunology.

[6]  C. Ciornei,et al.  Antimicrobial and Chemoattractant Activity, Lipopolysaccharide Neutralization, Cytotoxicity, and Inhibition by Serum of Analogs of Human Cathelicidin LL-37 , 2005, Antimicrobial Agents and Chemotherapy.

[7]  E. Fisher,et al.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Bennett,et al.  Tumor Necrosis Factor-&agr; Promotes Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis by Direct and Autocrine Mechanisms , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Zahler,et al.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.

[10]  C. Ciornei,et al.  Effects of human cathelicidin antimicrobial peptide LL‐37 on lipopolysaccharide‐induced nitric oxide release from rat aorta in vitro , 2003, Acta anaesthesiologica Scandinavica.

[11]  M. Bennett,et al.  Human Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis Requires NO Enhancement of Fas/Fas-L Interactions , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[12]  C. Ciornei,et al.  Bactericidal/permeability‐increasing protein inhibits endotoxin‐induced vascular nitric oxide synthesis , 2002, Acta anaesthesiologica Scandinavica.

[13]  R. Bals,et al.  Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. , 2002, American journal of respiratory and critical care medicine.

[14]  P. Shah.  Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. , 2002, Progress in cardiovascular diseases.

[15]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[16]  J. Calafat,et al.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.

[17]  J. Larrick,et al.  Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. , 2001, Biophysical journal.

[18]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[19]  H. Jörnvall,et al.  The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. , 2000, Blood.

[20]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[21]  A M Zeiher,et al.  Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. , 2000, Cardiovascular research.

[22]  M. Bennett,et al.  Human Blood-Derived Macrophages Induce Apoptosis in Human Plaque-Derived Vascular Smooth Muscle Cells by Fas-Ligand/Fas Interactions , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. Dominiczak,et al.  DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension. , 2000, Hypertension.

[24]  E. Greenberg,et al.  Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides , 2000, Infection and Immunity.

[25]  M. Bennett,et al.  An Introduction to Vascular Biology: The regulation of vascular smooth muscle cell apoptosis , 2002 .

[26]  Y. Shai,et al.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.

[27]  M. Ståhle-Bäckdahl,et al.  The Human Cationic Antimicrobial Protein (hCAP18), a Peptide Antibiotic, Is Widely Expressed in Human Squamous Epithelia and Colocalizes with Interleukin-6 , 1999, Infection and Immunity.

[28]  M. Rekhter,et al.  Collagen synthesis in atherosclerosis: too much and not enough. , 1999, Cardiovascular research.

[29]  H. Wellens,et al.  Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. , 1999, Cardiovascular research.

[30]  R. Gennaro,et al.  Cytotoxicity and apoptosis mediated by two peptides of innate immunity. , 1998, Cellular immunology.

[31]  R. Bals,et al.  The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Jacob,et al.  Apoptosis and related proteins in different stages of human atherosclerotic plaques. , 1998, Circulation.

[33]  A. Baker,et al.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.

[34]  K. Berndt,et al.  Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37* , 1998, The Journal of Biological Chemistry.

[35]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[36]  J. Cowland,et al.  An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. , 1997, Journal of immunological methods.

[37]  R. Hancock,et al.  Peptide antibiotics , 1997, The Lancet.

[38]  I. Wertz,et al.  Diverse molecular provocation of programmed cell death. , 1996, Trends in biochemical sciences.

[39]  J. Odeberg,et al.  The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. , 1996, European journal of biochemistry.

[40]  S. Orlov,et al.  Apoptosis in vascular smooth muscle cells: role of cell shrinkage. , 1996, Biochemical and biophysical research communications.

[41]  D. Gibson,et al.  Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. , 1995, Circulation research.

[42]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[43]  A. Johnsen,et al.  hCAP‐18, a cathelin/pro‐bactenecin‐like protein of human neutrophil specific granules , 1995, FEBS letters.

[44]  J. Larrick,et al.  Anti-microbial activity of human CAP18 peptides. , 1995, Immunotechnology : an international journal of immunological engineering.

[45]  J. Larrick,et al.  Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein , 1995, Infection and immunity.

[46]  J. Odeberg,et al.  FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.

[48]  A. Lichtenstein,et al.  Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. , 1991, The Journal of clinical investigation.

[49]  J. Barker,et al.  Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Yen,et al.  Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. , 2001, Cardiovascular research.

[51]  R. Gennaro,et al.  Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. , 2000, Biopolymers.

[52]  Y. Shai,et al.  Mode of action of linear amphipathic alpha-helical antimicrobial peptides. , 1998, Biopolymers.

[53]  P. Libby,et al.  Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[54]  Y. Hirata,et al.  Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. , 1994, Endocrinology.

[55]  T. Ganz,et al.  Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.